PATENT CLAIM ANALYSIS

Application Number: 15954021
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "009450"]

Abstract:
Disclosed herein are compositions and formulations containing a TATk-CDKL5 fusion protein. Also disclosed are methods of producing a TATk-CDKL5 fusion protein from vectors containing a TATk-CDKL5 cDNA and methods of transducing cells with the vectors containing a TATk-CDKL5 cDNA and the TATk-CDKL5 fusion protein

Claim (Index 56):
The method of  claim 50 , wherein administering the fusion protein reduces neuron apoptosis in the brain of a treated subject as compared to an untreated control subject.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14633757', '15075457', '14214161', '14518225', '15454662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7169750977067606
- 35 USC 102 Novelty (BERT): 0.6381496571744927
- Combined Prediction Score: 0.7090925536535339
- Mean Citation Score: 425.008982
- Max Citation Score: 667.46564
- Similarity Product: 523.8281037946367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test